Hydrocortisone-Induced Convulsions

Journal of Toxicology - Clinical Toxicology

Volumn 41, Issue 7, 2003, Pages 995-997

  Odeh, Majed ^a   Lavy, Alexandra ^a   Stermer, Edy ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Convulsions; Crohn's disease; Glucocorticoids; Hydrocortisone

Indexed keywords

CARBAMAZEPINE; DIAZEPAM; GLUCOCORTICOID; HYDROCORTISONE; MERCAPTOPURINE; PHENYTOIN; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; CONVULSION; CROHN DISEASE; ELECTROLYTE DISTURBANCE; FEMALE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; NEUROTOXICITY;

ADULT; ANTI-INFLAMMATORY AGENTS; CROHN DISEASE; FEMALE; HUMANS; HYDROCORTISONE; INFUSIONS, INTRAVENOUS; SEIZURES;

EID: 0346103793     PISSN: 07313810     EISSN: None     Source Type: Journal    
DOI: 10.1081/CLT-120026524     Document Type: Article

References (18)

1. Roberts AJ, Crabbe JC, Keith LD. Type I corticosteroids receptors modulate PTZ-induced convulsions of withdrawal seizure prone mice. Brain Res 1993; 626:143-148.
2. Report from Boston Collaborative Drug Surveillance Program. Drug-induced convulsions. Lancet 1972; 2:677-679.
3. Bettinelli A, Paterlini G, Mazzucchi E, Giani M. Seizures and transient blindness following intravenous pulse methyl-prednisolone in children with primary glomerulonephritis. Child Nephrol Urol 1991; 11:41-43.
4. El-Dahr S, Chevalier RL, Gomez RA, Campell FG. Seizures and blindness following intravenous pulse methylprednisolone in a renal transplant patient. Int J Pediatr Nephrol 1987; 8:87-90.
5. Yu EC, Wong SN, Yeung CY. Encephalopathy associated with steroid treated nephrotic syndrome. Int Pediatr Nephrol 1987; 8:135-146.
6. Durrant S, Chipping PM, Palmer S. Cyclosporin A, methyl-prednisolone and convulsions. Lancet 1982; 27:829.
7. Boogaerts MA, Zachee P, Verurlghen RL. Cyclosporine, methyl-prednisolone and convulsions. Lancet 1982; 27:1216.
8. Yang JY, Cui XL, He XJ. Non-ketotic hyperosmolar coma complicating steroid treatment in childhood nephrosis. Pediatr Nephrol 1995; 9:621-622.
9. Ildirim I, Furcolow ML, Vandiviere HM. A possible explanation of post-treatment convulsions associated with intrathecal corticosteroids. Neurology 1970; 20:622-625.
10. Roberts AJ, Keith LD. Mineralocorticoid receptors mediate the enhancing effects of corticosterone on convulsion susceptibility in mice. J Pharmacol Exp Ther 1994; 270:505-511.
11. Reddy DS, Kulkarni SK. Proconvulsant effects of neurosteroids pregnenolone sulfate and dehydroepiandrosterone sulfate in mice. Eur J Pharmacol 1998; 345:55-59.
12. Kokate TG, Juhng KN, Kirkby RD, Llamas J, Yamaguchi S, Rogawski MA. Convulsant actions of the neurosteroid pregnenolone sulfate in mice. Brain Res 1999; 831:119-124.
13. Rolla G, Bucca C, Bugiani M, Oliva A, Branciforte L. Hypomagnesemia in chronic obstructive lung disease: effect of therapy. Magnes Trace Elem 1990; 9:132-136.
14. Galland L. Magnesium, stress, and neuropsychiatric disorders. Magnes Trace Elem 1991; 10:287-301.
15. Ghezzi A, Zaffaroni M. Neurological manifestations of gastrointestinal disorders, with particular reference to the differential diagnosis of multiple sclerosis. Neurol Sci 2001; 22:S117-S122.
16. Lossos A, River Y, Eliakim A, Steiner I. Neurologic aspects of inflammatory bowel disease. Neurology 1995; 45:416-421.
17. Gendelman S, Present D, Janowitz HD. Neurological complications of inflammatory bowel disease (IBD) [Abstract]. Gastroenterology 1982; 82:1065.
18. Elsebety AE, Bertorini TE. Neurological complications in Crohn's disease [Abstract]. Ann Neurol 1991; 30:271.